Skip to content
  • Follow Us

CarboHyde

SUGAR IS LIFE

  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog
  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

CarboHyde

SUGAR IS LIFE

  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

Tag: nanomedicine

Micro and nanotechnologies: The little formulations that could

Feb 9, 2023Tamas Sohajdadrug deliverynanomedicine, nanoparticles

Fantastic article on the evolution of micro and nanotechnologies from Rebeca Stiepel, Eliza Duggan, Cole J. Batty, Kristy Ainslie (University of North Carolina at Chapel Hill). How far we have come already! And what could be the road ahead?

See the full article here

Categories

  • carbohydrates
  • drug delivery
  • drug development
  • drug discovery
  • Egyéb kategória
  • news
  • Today's cyclodextrin

Archive

  • March 2023 (45)
  • February 2023 (34)
  • January 2023 (31)
  • December 2022 (23)
  • November 2022 (33)
  • October 2022 (38)
  • September 2022 (9)

Latest posts

  • Novoxyne and CarboHyde explore together cyclodextrin-based methods to reprogram somatic cells
  • Lysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin
  • Use of cyclodextrin to enhance solubility of substrates and increase enzymatic glycosylation reaction efficiency

Subscribe to our newsletter

alzheimers analytical chemistry anticancer atherosclerosis cancer research cancer treatment carbohyde cardiovascular chemistry cholesterol clinical trial covid19 cyclodextrin drug delivery formulation development gene therapy glycotime green chemistry infectious diseases monoclonal antibodies neurodegenerative diseases oncology research rare disease scientific advisory board synthesis

Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter